Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates as anticancer drugs.

Mundy1

  • 1Division of Medicine/Endocrinology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78284-7877, USA. grmos@aol.com

Expert Opinion on Investigational Drugs
|January 5, 2001
PubMed
Summary

Bisphosphonates, like pamidronate, are crucial for treating bone metastases. Emerging research suggests these drugs may also reduce tumor burden in bone, offering new hope for advanced cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Human Genome Project - obstacles versus opportunities.

Drug discovery today·2000
Same author

Oxygen tracer diffusion in YBa2Cu4O8.

Physical review. B, Condensed matter·1993
Same author

Diffusion of 18O in Bi2Sr2CuOx single crystals.

Physical review. B, Condensed matter·1992
Same author

Renormalization of a Landau-Ginzburg-Wilson theory of microemulsion.

Physical review. A, Atomic, molecular, and optical physics·1992
Same author

Tracer diffusion of oxygen in Bi2Sr2CaCu2Ox.

Physical review. B, Condensed matter·1992
Same author

Site selectivity and cation diffusion in YBa2Cu3O7- delta.

Physical review. B, Condensed matter·1991

Area of Science:

  • Oncology
  • Pharmacology
  • Bone Metastasis Research

Background:

  • Pamidronate is a key treatment for osteolytic bone disease in cancers like breast cancer and myeloma.
  • Bisphosphonates traditionally target bone resorption, but new effects are being discovered.

Purpose of the Study:

  • To investigate the potential anti-tumor effects of bisphosphonates beyond bone resorption inhibition.
  • To explore if bisphosphonates can reduce tumor burden in bone.

Main Methods:

  • Studies involved human breast cancer cells in nude mice to observe bisphosphonate effects on tumor burden and osteolysis.
  • Preliminary patient studies with clodronate were analyzed for effects on bone tumor burden.

Main Results:

  • Some bisphosphonates demonstrated a reduction in tumor burden within bone, alongside decreased osteolysis in preclinical models.
  • Initial patient data suggest clodronate may decrease tumor burden in bone.

Conclusions:

  • Preliminary findings indicate bisphosphonates might possess direct anti-cancer effects in bone, impacting tumor burden.
  • Further research is needed to determine specific bisphosphonate efficacy, tumor type relevance, and underlying mechanisms (e.g., apoptosis).
  • Large, multi-center studies are required to overcome confounding variables in patient data and reach definitive conclusions.

Related Experiment Videos